Integrated… Industry Segments.
Locust Walk has a strong understanding of value drivers, deal structures, and transaction precedents as well as how they differ between the biopharma and medtech segments.
For life science companies, this means:
- Strong understanding of value drivers, deal structures, and transaction precedents as well as how they differ between the biopharma and medtech segments.
- Biopharma team has completed over 40 transactions at Locust Walk across a range of therapeutic areas, modalities, and all stages of development and marketed products.
- Medtech team brings deep, segment-specific experience from over 25 transactions across various therapeutic areas and care settings for medical device, diagnostics, tools and digital health companies.
- Strong understanding of both the biopharma and medtech segments helps our team identify and maximize the potential of convergence opportunities that many innovative life science companies have top-of-mind.
Want to learn more about how our integrated team-based approach to transactions to help you get the right deals done?